NGL Fine-Chem Ltd Share Price

₹1279.35 -30.75 (-2.35%) BSE
as updated on 19-Dec-2025 16:59 | Sector - Healthcare

Day Range

  • Day's Low:1279.30
  • Day's High:1299.35

  • 52 Week Low962.70
  • 52 Week High2161.00

NGL Fine-Chem Ltd's key Fundamentals

Market Cap ₹790 Cr.
P/E Ratio 50
TTM EPS 25.6
P/B Ratio 2.69
ROE 5.96
Debt to Equity 0.27
Face Value 5
BVPS 475.8
3 Year Sales Growth 4.08%

NGL Fine-Chem Ltd's Share Price Returns

1 Day -2.35%
1 Week -2.60%
1 Month -8.20%
3 Months -9.10%
6 Months 27.90%
1 Years -36.90%
3 Years -22.00%
5 Years 13.70%
10 Years 0%

Financial Ratio Analysis

Adj EPS (Rs.)
Sales (Cr.)
ROE (%)
ROCE (%)

Check our DeciZen before investing

Check Stock Quality
Check Stock Valuation
Check Price Trend

NGL Fine-Chem Ltd Shareholding Pattern

Promoters

(72.74%)

Institutions

(0.00%)

Non-Institutions

(27.26%)

Pledged shares as % of Promoter's holding (%)

(0.00%)

Top 5 Mutual Funds Holding

Last Visited Stocks

Balance Sheet

(All Figures are in Crores.)

Profit And Loss

(All Figures in Cr. Adjusted EPS in Rs.)

Cash Flow

(All Figures are in Crores.)

About NGL Fine-Chem Ltd

NGL Fine-chem  is a manufacturer of pharmaceuticals and intermediates for usage in veterinary and human health. It caters to various global companies to custom manufacture high quality pharmaceuticals with reliability and flexibility.

Its business is modelled around the changing customer demands and their ability to offer value-added innovative solutions to meet and even exceed these demands.

Utilizing its expertise in complex multi-stage organic synthesis, it continues to expand the product portfolio with new products.

It has established a strong presence in global pharmaceutical companies with its commitment to competitive prices, delivery schedules, international quality standards and constant technological upgradation.

NGL Fine-chem Ltd has a strong focus on developing intellectual property as a key differentiator and as a platform for further growth up the pharma value chain. It respect intellectual property and invest in developing it as a key growth driver for the future.

Product range of the company includes:

Pharmaceutical like Diminazene Aceturate, Diminazene Diaceturate, Homidium Chloride, Nitroxynil, Clorsulon, Homidium Bromide, Parvaquone, Carprofen, Buparvaquone and Isometamidium Chloride Hydrochloride for:

  • Animal health
  • Human health
  • Intermediate- 4 Aminobenzamidine Dihydrochloride, 3 Aminobenzamidine Dihydrochloride, Ezetimibe Intermediates etc
  • Finished dosages form- Homidium Chloride Tablets, Diminazene Aceturate Granules

Achievements/ recognition

An ISO 9001:2000 accredited company

Read More Read Less
Read More Read Less

Investment related blogs

Day Range

  • Day's Low: 1279.30
  • Day's High: 1299.35

  • 52 Week Low962.70
  • 52 Week High2161.00

NGL Fine-Chem Ltd's key Fundamentals

Market Cap ₹790 Cr.
P/E Ratio 50
TTM EPS 25.6
P/B Ratio 2.69
ROE 5.96
Debt to Equity 0.27
Face Value 5
BVPS 475.8
3 Year Sales Growth 4.08%

NGL Fine-Chem Ltd's Share Price Returns

1 Day -2.35%
1 Week -2.60%
1 Month -8.20%
3 Months -9.10%
6 Months 27.90%
1 Years -36.90%
3 Years -22.00%
5 Years 13.70%
10 Years 0%

Investment related blogs

© 2025 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt. Ltd.

×